START FREE TRIAL

Palantir Venezuela Maduro Impact: The Real Story Behind the Headlines!

Shares of Palantir Technologies (NYSE:PLTR) jumped after a dramatic weekend operation in which Venezuelan leader Nicolás Maduro was captured...

Tesla 2025 EV Deliveries Decline: Europe Turns Its Back on Musk

Tesla (NASDAQ:TSLA) just reported a bruising end to 2025. Fourth-quarter deliveries came in at 418,227 units—down 16% from the...

Target Activist Investor Stake: What a $5B Catalyst Means for Stores, Labor & Margins

Target (NYSE:TGT) had a bruising 2025. Sales slid for the second straight year, the stock dropped 28%, and the...

Meta Acquires Manus: The Real Reason Behind Zuckerberg’s $2 Billion AI Gamble

Meta Platforms (NASDAQ:META) just made another bold AI move. In a deal reportedly valued north of $2 billion, Meta...

An Investor’s Guide To Intrinsic Value Calculation & Relative Valuation

Valuation can feel intimidating when you first encounter it. There are formulas everywhere, specialized jargon, and spreadsheets packed with...

Nvidia Groq AI Licensing Deal Hints At What Comes After GPU Dominance

On Christmas Eve, when markets were thin and inboxes quiet, Nvidia (NASDAQ:NVDA) dropped a small but revealing piece of...

Chevron Venezuela Oil Investment: Trump’s Secret Weapon Against Maduro?

Chevron’s (NYSE:CVX) century-long presence in Venezuela is turning into a high-stakes test of geopolitics, oil strategy, and corporate resilience....

Sterling Anderson GM Leadership Gamble: Can a Tesla Defector Save General Motors?

Sterling Anderson’s journey from clashing with Elon Musk to reshaping General Motors (NYSE:GM) may be one of the most...

Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!

If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...

Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace

On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace Manufacturing (CAM) from Stanley Black &...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

Meta Mango Image Video AI Is Coming for Google’s Nano Banana & Adobe!!

Meta Platforms (NASDAQ:META) is getting serious about becoming a true AI heavyweight. In its most recent Q3 2025 earnings...